Global Pharmatech Inc
Global Pharmatech, Inc., through its subsidiaries, discovers, develops, manufactures, and markets proprietary therapeutical products based on Traditional Chinese Medicine (TCM). The company was founded in 2001 and is based in Mong Kok, Hong Kong.
Global Pharmatech Inc (GBLP) - Total Assets
Latest total assets as of June 2025: $854.68K USD
Based on the latest financial reports, Global Pharmatech Inc (GBLP) holds total assets worth $854.68K USD as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Global Pharmatech Inc - Total Assets Trend (2001–2024)
This chart illustrates how Global Pharmatech Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Global Pharmatech Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
Global Pharmatech Inc's total assets of $854.68K consist of 51.4% current assets and 48.6% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 4.0% |
| Accounts Receivable | $328.30K | 43.7% |
| Inventory | $27.90K | 3.7% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2001–2024)
This chart illustrates how Global Pharmatech Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Global Pharmatech Inc's current assets represent 51.4% of total assets in 2024, an increase from 0.0% in 2001.
- Cash Position: Cash and equivalents constituted 4.0% of total assets in 2024, down from 84.0% in 2001.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2001.
- Asset Diversification: The largest asset category is accounts receivable at 43.7% of total assets.
Global Pharmatech Inc Competitors by Total Assets
Key competitors of Global Pharmatech Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
General Mills Inc
NYSE:GIS
|
USA | $32.55 Billion |
|
Maniker F & G Co. Ltd
KQ:195500
|
Korea | ₩123.42 Billion |
|
Xiwang Foodstuffs Co Ltd
SHE:000639
|
China | CN¥6.08 Billion |
|
Nanfang Black Sesame Group Co Ltd
SHE:000716
|
China | CN¥4.57 Billion |
|
CNFC Overseas Fishery Co Ltd
SHE:000798
|
China | CN¥5.88 Billion |
|
Henan Shuanghui Investment & Development Co Ltd
SHE:000895
|
China | CN¥40.64 Billion |
|
Xinjiang Chalkis Co Ltd
SHE:000972
|
China | CN¥1.25 Billion |
|
Daehan Flour Mills Co Ltd
KO:001130
|
Korea | ₩1.61 Trillion |
Global Pharmatech Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Global Pharmatech Inc generates 0.41x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Global Pharmatech Inc is currently not profitable relative to its asset base.
Global Pharmatech Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.54 | 0.36 | 6.63 |
| Quick Ratio | 0.43 | 0.32 | 5.73 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-423.70K | $ -440.75K | $ 7.19 Million |
Global Pharmatech Inc - Advanced Valuation Insights
This section examines the relationship between Global Pharmatech Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.18 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 85.1% |
| Total Assets | $751.93K |
| Market Capitalization | $2.19K USD |
Valuation Analysis
Below Book Valuation: The market values Global Pharmatech Inc's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Global Pharmatech Inc's assets grew by 85.1% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Global Pharmatech Inc (2001–2024)
The table below shows the annual total assets of Global Pharmatech Inc from 2001 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $751.93K | +85.11% |
| 2023-12-31 | $406.22K | -5.08% |
| 2022-12-31 | $427.95K | +30208.00% |
| 2021-12-31 | $1.41K | -99.99% |
| 2007-12-31 | $13.35 Million | -17.36% |
| 2006-12-31 | $16.15 Million | +32.50% |
| 2005-12-31 | $12.19 Million | +14.43% |
| 2005-03-31 | $10.65 Million | +11.33% |
| 2004-12-31 | $9.57 Million | +4684.51% |
| 2001-12-31 | $200.00K | -- |